SCHEMBL9955323

SCHEMBL9955323

Cc1n[c]oc1-c1cccc(Cl)c1

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ESR2 Q92731 1/20 0.44
PTGS1 P23219 1/20 0.41
PTGS2 P35354 1/20 0.41
TP53 P04637 3/20 0.40
NPC1 O15118 2/20 0.40
RAB9A P51151 2/20 0.40
TSHR P16473 1/20 0.40
NFKB1 P19838 1/20 0.40
NFKB2 Q00653 1/20 0.40
RELA Q04206 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
NOTUM Q6P988 2/20 0.39
ALDH1A1 P00352 1/20 0.39
CYP1A2 P05177 1/20 0.39
IKBKE Q14164 1/20 0.39
MAPT P10636 1/20 0.38
KMT2A Q03164 1/20 0.38
PGR P06401 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9956367 0.83 RAB9A (0.42) TP53NPC1RAB9ATSHRSMN1; SMN2
SCHEMBL9955349 0.80 NOTUM (0.39) ESR2TP53SMN1; SMN2NOTUMPGR
SCHEMBL4511404 0.78 BRD4 (0.38) PTGS1PTGS2NPC1RAB9ATSHR
SCHEMBL9956239 0.77 PTGS1 (0.51) ESR2PTGS1PTGS2TP53NPC1
SCHEMBL5546758 0.71 ALDH1A1 (0.48) ESR2PTGS1PTGS2TP53NPC1
SCHEMBL9953638 0.71 NOTUM (0.47) ESR2PTGS1PTGS2TP53NPC1
SCHEMBL9954839 0.71 NPC1 (0.45) ESR2PTGS1PTGS2TP53NPC1
SCHEMBL4939446 0.68 TDO2 (0.53) ESR2PTGS1PTGS2TP53NPC1
SCHEMBL6170416 0.68 PTGS1 (0.60) PTGS1PTGS2TP53NPC1RAB9A
SCHEMBL9955814 0.67 KMT2A (0.41) ESR2PTGS1PTGS2TP53NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012085852-A1 3,8-DIAZA-BICYCLO[4.2.0]OCT-8-YL AMIDES ACTELION PHARMACEUTICALS LTD (CH) 2012-06-28 WO disclosed
WO-2012085857-A1 3,8-DIAZA-BICYCLO[4.2.0]OCT-3-YL AMIDES ACTELION PHARMACEUTICALS LTD (CH) 2012-06-28 WO disclosed